Aprogen Acquires Additional 100 Million Shares of Subsidiary Aprogen Pharmaceuticals

[Asia Economy Reporter Gong Byung-sun] Aprogen announced on the 4th that it will additionally acquire 100 million shares of its pharmaceutical manufacturing and sales affiliate, Aprogen Pharm, for 50 billion KRW.

After the stock acquisition, Aprogen's stake in Aprogen Pharm will be 56%. The scheduled date for the stock acquisition is December 10. Aprogen stated, "The shares were acquired for the purpose of investing in new business."